| AB(s) | Antibiotic(s) |
| AMK | Amikacin |
| AMP | Ampicillin |
| AMC | Amoxicillin + clavulanic acid |
| CXM | Cefuroxime |
| CFX | Cefotaxime |
| CAZ | Ceftazidim |
| CIP | Ciprofloxacin |
| CRO | Ceftriaxone |
| GEN | Gentamicin |
| LEV | Levofloxacin |
| NAL | Nalidixic acid |
| NFN | Nitrofurantoin |
| NOR | Norfloxacin |
| PIP | Piperacillin |
| SXT | Trimethoprim + Sulfamethoxazol |
| TET | Tetracyclin |
| AMC | antibiotic consumption |
| AMR | Antimicrobial Resistance |
| C.L.E.D. Agar | Cystine Lactose Electrolyte Deficient Agar |
| CLSI | Clinical and Laboratory Standards Institute |
| EAU | European Association of Urology |
| ECDC | European Centre for Disease Prevention |
| ESBL | extended-spectrum β-lactamase-producing |
| GLASS | Global Antimicrobial Resistance and Use Surveillance System |
| HIC(s) | High-income country/-ies |
| LIC(s) | Low-income country/-ies |
| Max. | Maximum |
| Min. | Minimum |
| MMCH | Margret Marquart Catholic Hospital |
| MP/CK | Mobile phones/computer keyboards |
| NA | Not available |
| OR | Odds ratio |
| SD | Standard deviation |
| spp. | Species |
| USA | United states of America |
| UTI | urinary tract infection |
| WHO | World Health Organization |